Citations

Showing 10 of 108104 citations.

Report of the 24th Annual Congress of the International Liver Transplantation Society
Martin, Eléonora De , Hessheimer, Amelia J. , Kabaçam, Gökhan , Rajanayagam, Jeremy, Kirchner, Varvara A. , Kalisvaart, Marit , Scalera, Irene , Bhat, Mamatha , Contreras, Alan G. , Bhat, Mamatha , Kirchner, Varvara , Chadha, Ryan , Bhangui, Prashant

Mayo Clinic

Transplantation | November 21, 2018 | Volume: 103 | Issue: 3 | Pages: 465-469

10.1097/tp.0000000000002549 | PMID 30461723 Get It

The 24th Joint Annual Congress of the International Liver Transplantation Society in association with European Liver and Intestine Transplant Association and Liver Intensive Care Group of Europe was held in Lisbon, Portugal from May 23 to 26, 2018. More than 1200 participants from over 60 countries including surgeons, hepatologists, anesthesiologists and critical care intensivists, radiologists, pathologists, organ procurement personnel, and research scientists came together with the common aim of improving care and outcomes for liver transplant recipients. Over 600 scientific abstracts were presented. The principal themes were living donation, use of marginal liver donors, machine preservation, disease-specific immunosuppressive regimen, malignancies, and advances in pediatric liver transplantation and liver transplant anesthesia. This report presents excerpts from invited lectures and select abstracts from scientific sessions, which add to current knowledge, and will drive clinical practice and future research.
Long‐term outcomes of melody valve‐in‐valve implantation for bioprosthetic mitral valve dysfunction
Joseph, Timothy A. , Eleid, Mackram F. , Maalouf, Joseph F., Rihal, Charanjit S. , Cabalka, Allison K. , Joseph, Timothy A. , Rihal, Charanjit S.

Mayo Clinic

Catheterization and Cardiovascular Interventions | November 21, 2018 | Volume: 93 | Issue: 6 | Pages: 1087-1094

10.1002/ccd.27988 | PMID 30461167 Get It

AbstractObjectivesThis study reports long‐term outcomes percutaneous Melody valve (Medtronic, Minneapolis, Minnesota) valve‐in‐valve therapy in patients with prosthetic valve dysfunction.BackgroundRepeat valve surgery is associated with high morbidity and mortality. Transcatheter mitral valve‐in‐valve is a promising alternative in patients at high‐risk for cardiac surgery.MethodsWe conducted a retrospective cohort analysis of 13 patients who underwent Melody valve‐in‐valve for bioprosthetic dysfunction from July 2011 to October 2013.ResultsMean age was 74.4 years, 46% male, and STS score 13.5 ± 6.8%. All patients had NYHA class 3 or 4 symptoms with improvement to class 1 or 2 in 82% post procedure. Median follow‐up was 4.5 years with longest follow‐up of 5.5 years. Thirty‐day mortality was 15.4% with 1‐year mortality of 25% and no other reported deaths until 4.5 years. 76.9% of patients had mitral gradient of 5 mmHg or less immediately postprocedure. One patient required repeat valve procedure for structural deterioration at 4.4 years. At 1, 3, and 5 year follow‐ups 75% of patients were NYHA class 1 or 2, mean gradients were 4.5 ± 0.6, 6.8 ± 0.5, and 7.5 ± 0.7, respectively. Using 4‐point scale, mitral regurgitation postprocedure was 0.8 ± 0.6. At 1, 3, and 5 years this increased to 1.0 ± 1.1, 1.3 ± 1.3, and 2.5 ± 2.1, respectively.ConclusionsMelody valve‐in‐valve therapy was effective with 1‐year symptomatic improvement. Prosthesis deterioration requiring repeat intervention was observed in one patient. Larger cohorts with multicenter registries are needed to determine the role of this percutaneous valve‐in‐valve therapy as valve technology and procedural techniques improve.
Absorbable subcuticular staples versus suture for caesarean section closure: a randomised clinical trial
Madsen, Annetta M. , Dow, ML, Lohse, CM, Tessmer‐Tuck, JA

Mayo Clinic

BJOG: An International Journal of Obstetrics & Gynaecology | November 21, 2018 | Volume: 126 | Issue: 4 | Pages: 502-510

10.1111/1471-0528.15532 | PMID 30461155 Get It

ObjectiveTo compare outcomes of efficiency, safety, patient, and surgeon satisfaction between absorbable subcuticular staples and subcuticular suture for caesarean section skin closure.DesignA prospective, randomised, non‐blinded, parallel‐group trial.SettingMayo Clinic Family Birth Center in Rochester, MN, USA.PopulationAt least 18 years old and 24 weeks’ gestation, undergoing caesarean section. Exclusion criteria were body mass index >50, chorioamnionitis, intrauterine fetal death, and multifetal gestation.MethodsPatients were stratified by prior caesarean section, body mass index, and surgeon level and randomised to absorbable subcuticular staples or subcuticular suture. Electronic medical records and surveys were used.Main outcome measuresPrimary outcomes were total operating time, from incision start to close. Secondary outcomes included subcuticular skin closure time, patient and surgeon satisfaction, percutaneous injuries, pain (analgesic use), cosmesis, and wound complications.ResultsOf 220 randomised patients, 206 were included in the final analysis (103 per group). Baseline characteristics were similar. The primary outcome of total operative time was not significantly different between groups [54.0 (44.9–63.6) versus 58.0 (50.4–68.2) minutes, P = 0.053]. The subcuticular staple group had shorter subcuticular skin closure time [median 2.6 (1.8–4.0) versus 8.5 (6.2–10.5) minutes, P < 0.001]. There were no differences in analgesic use, wound complications, cosmesis or patient satisfaction. One needlestick injury occurred with suture. Surgeons were more likely to recommend (97% versus 85%, P = 0.004) and use (98% versus 82%, P < 0.001) absorbable subcuticular staples.ConclusionFor caesarean section skin closure, absorbable subcuticular staples did not result in significantly different total operative times compared with sutures. Analgesic use, wound complications, and cosmesis were comparable. Patient and surgeon satisfaction were high with both methods.Tweetable abstractAbsorbable subcuticular staples associated with a similar total operative time compared with suture.
High-Resolution Chest Computed Tomography Imaging of the Lungs
Bartlett, David J. , Koo, Chi Wan , Bartholmai, Brian J. , Weaver, Jayse , Halaweish, Ahmed F., Bartholmai, Brian J , Rajendran, Kishore , Leng, Shuai , McCollough, Cynthia H. , Fletcher, Joel G.

Mayo Clinic

Investigative Radiology | November 21, 2018 | Volume: 54 | Issue: 3 | Pages: 129-137

10.1097/rli.0000000000000524 | PMID 30461437 Get It

Objectives The aim of this study was to evaluate if a high-resolution photon-counting detector computed tomography (PCD-CT) system with a 1024×1024 matrix reconstruction can improve the visualization of fine structures in the lungs compared with conventional high-resolution CT (HRCT). Materials and Methods Twenty-two adult patients referred for clinical chest HRCT (mean CTDI vol, 13.58 mGy) underwent additional dose-matched PCD-CT (mean volume CT dose index, 13.37 mGy) after written informed consent. Computed tomography images were reconstructed at a slice thickness of 1.5 mm and an image increment of 1 mm with our routine HRCT reconstruction kernels (B46 and Bv49) at 512 and 1024 matrix sizes for conventional energy-integrating detector (EID) CT scans. For PCD-CT, routine B46 kernel and an additional sharp kernel (Q65, unavailable for EID) images were reconstructed at 1024 matrix size. Two thoracic radiologists compared images from EID and PCD-CT noting the highest level bronchus clearly identified in each lobe of the right lung, and rating bronchial wall conspicuity of third- and fourth-order bronchi. Lung nodules were also compared with the B46/EID/512 images using a 5-point Likert scale. Statistical analysis was performed using a Wilcoxon signed rank test with a P < 0.05 considered significant. Results Compared with B46/EID/512, readers detected higher-order bronchi using B46/PCD/1024 and Q65/PCD/1024 images for every lung lobe (P < 0.0015), but in only the right middle lobe for B46/EID/1024 (P = 0.007). Readers were able to better identify bronchial walls of the third- and fourth-order bronchi better using the Q65/PCD/1024 images (mean Likert scores of 1.1 and 1.5), which was significantly higher compared with B46/EID/1024 or B46/PCD/1024 images (mean difference, 0.8; P < 0.0001). The Q65/PCD/1024 images had a mean nodule score of 1 ± 1.3 for reader 1, and −0.1 (0.9) for reader 2, with one reader having improved nodule evaluation scores for both PCD kernels (P < 0.001), and the other reader not identifying any increased advantage over B46/EID/1024 (P = 1.0). Conclusions High-resolution lung PCD-CT with 1024 image matrix reconstruction increased radiologists' ability to visualize higher-order bronchi and bronchial walls without compromising nodule evaluation compared with current chest CT, creating an opportunity for radiologists to better evaluate airway pathology.
ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS
Barale, Pierre‐Olivier, Ayello‐Scheer, Sarah , Devenyi, Robert G., Rachitskaya, Aleksandra , Yuan, Alex , Jayasundera, Thiran , Zacks, David N. , Handa, James T. , Koozekanani, Dara D., Stanga, Paulo , Cruz, Lyndon da , Walter, Peter , Chizzolini, Marzio, Koo, Lisa C. Olmos de , Ho, Allen C. , Kirchhof, Bernd , Vajzovic, Lejla , Iezzi, Raymond , Arevalo, J. Fernando, Gregori, Ninel Z., Özmert, Emin , Yoon, Young Hee , Kokame, Gregg T. , Lim, Jennifer I. , Szurman, Peter , Juan, Eugene de, Rezende, Flávio , Salzmann, Joël, Richard, Gisbert, Huang, Suber S., Merlini, Francesco, Patel, Uday , Greenberg, Robert J., Justus, Sally, Cinelli, Laura, Humayun, Mark S. , Rizzo, Stanislao , Barale, P.O., Delyfer, Marie‐Noëlle , Korobelnik, Jean‐François , Montezuma, Sandra Rocio , Augustin, Albert J. , Hahn, Paul , Gaucher, David , Grisanti, Salvatore, Huang, Suber S., Merlini, Francesco, Cruz, Cynthia

Mayo Clinic

Retina | November 21, 2018 | Volume: 40 | Issue: 2 | Pages: 303-311

10.1097/iae.0000000000002394 | PMID 31972801 Get It

Purpose: To analyze and provide an overview of the incidence, management, and prevention of conjunctival erosion in Argus II clinical trial subjects and postapproval patients. Methods: This retrospective analysis followed the results of 274 patients treated with the Argus II Retinal Prosthesis System between June 2007 and November 2017, including 30 subjects from the US and European clinical trials, and 244 patients in the postapproval phase. Results were gathered for incidence of a serious adverse event, incidence of conjunctival erosion, occurrence sites, rates of erosion, and erosion timing. Results: Overall, 60% of subjects in the clinical trial subjects versus 83% of patients in the postapproval phase did not experience device- or surgery-related serious adverse events. In the postapproval phase, conjunctival erosion had an incidence rate of 6.2% over 5 years and 11 months. In 55% of conjunctival erosion cases, erosion occurred in the inferotemporal quadrant, 25% in the superotemporal quadrant, and 20% in both. Sixty percent of the erosion events occurred in the first 15 months after implantation, and 85% within the first 2.5 years. Conclusion: Reducing occurrence of conjunctival erosion in patients with the Argus II Retinal Prosthesis requires identification and minimization of risk factors before and during implantation. Implementing inverted sutures at the implant tabs, use of graft material at these locations as well as Mersilene rather than nylon sutures, and accurate Tenon's and conjunctiva closure are recommended for consideration in all patients.
Cardiac and skeletal actin substrates uniquely tune cardiac myosin strain-dependent mechanics
Wang, Yihua , Ajtai, Katalin , Burghardt, Thomas P.

Mayo Clinic

Open Biology | November 21, 2018 | Volume: 8 | Issue: 11 | Pages: 180143

10.1098/rsob.180143 | PMID 30463911 Get It

Cardiac ventricular myosin (βmys) translates actin by transducing ATP free energy into mechanical work during muscle contraction. Unitary βmys translation of actin is the step-size. In vitro and in vivo βmys regulates contractile force and velocity autonomously by remixing three different step-sizes with adaptive stepping frequencies. Cardiac and skeletal actin isoforms have a specific 1 : 4 stoichiometry in normal adult human ventriculum. Human adults with inheritable hypertrophic cardiomyopathy (HCM) upregulate skeletal actin in ventriculum probably compensating the diseased muscle's inability to meet demand by adjusting βmys force–velocity characteristics. βmys force–velocity characteristics were compared for skeletal versus cardiac actin substrates using ensemble in vitro motility and single myosin assays. Two competing myosin strain-sensitive mechanisms regulate step-size choices dividing single βmys mechanics into low- and high-force regimes. The actin isoforms alter myosin strain-sensitive regulation such that onset of the high-force regime, where a short step-size is a large or major contributor, is offset to higher loads probably by the unique cardiac essential light chain (ELC) N-terminus/cardiac actin contact at Glu6/Ser358. It modifies βmys force–velocity by stabilizing the ELC N-terminus/cardiac actin association. Uneven onset of the high-force regime for skeletal versus cardiac actin modulates force–velocity characteristics as skeletal/cardiac actin fractional content increases in diseased muscle.
Effect of Modified Japanese Orthopedic Association Severity Classifications on Satisfaction With Outcomes 12 Months After Elective Surgery for Cervical Spine Myelopathy
Asher, Anthony L. , Devin, Clinton J. , Weisenthal, Benjamin M., Pennings, Jacquelyn S. , Khan, Inamullah , Archer, Kristin R. , Sivaganesan, Ahilan, Chotai, Silky , Bydon, Mohamad , Nian, Hui , McGirt, Matthew J., Mummaneni, Praveen V. , Bisson, Erica F. , Shaffrey, Christopher I. , Foley, Kevin T. , Harrell, Frank E.

Mayo Clinic

Spine | November 21, 2018 | Volume: 44 | Issue: 11 | Pages: 801-808

10.1097/brs.0000000000002946 | PMID 30475334 Get It

Study Design. This study retrospectively analyzes prospectively collected data. Objective. Here, we aim to determine the influence of preoperative and 12-month modified Japanese Orthopedic Association (mJOA) on satisfaction and understand the change in mJOA severity classification after surgical management of degenerative cervical myelopathy (DCM). Summary of Background Data. DCM is a progressive degenerative spine disease resulting from cervical cord compression. The natural progression of DCM is variable; some patients experience periods of stability, while others rapidly deteriorate following disease onset. The mJOA is commonly used to grade and categorize myelopathy symptoms, but its association with postoperative satisfaction has not been previously explored. Methods. The quality and outcomes database (QOD) was queried for patients undergoing elective surgery for DCM. Patients were divided into mild (≥14), moderate (9 to 13), or severe (<9) categories on the mJOA scores. A McNemar–Bowker test was used to assess whether a significant proportion of patients changed mJOA category between preoperative and 12 months postoperative. A multivariable proportional odds ordinal logistic regression model was fitted with 12-month satisfaction as the outcome of interest. Results. We identified 1963 patients who underwent elective surgery for DCM and completed 12-months follow-ups. Comparing mJOA severity level preoperatively and at 12 months revealed that 55% remained in the same category, 37% improved, and 7% moved to a worse category. After adjusting for baseline and surgery-specific variables, the 12-month mJOA category had the highest impact on patient satisfaction (P < 0.001). Conclusion. Patient satisfaction is an indispensable tool for measuring quality of care after spine surgery. In this sample, 12-month mJOA category, regardless of preop mJOA, was significantly correlated with satisfaction. Given these findings, it is important to advise patients of the probability that surgery will change their mJOA severity classification and the changes required to achieve postoperative satisfaction. Level of Evidence: 3
Phase 2 study of all‐oral ixazomib, cyclophosphamide and low‐dose dexamethasone for relapsed/refractory multiple myeloma
Kumar, Shaji , Grząśko, Norbert , Wiktor-Jędrzejczak, W , Grosicki, Sebastian , Kyrtsonis, Marie‐Christine , Spencer, Andrew , Gupta, Neeraj , Teng, Zhaoyang , Byrne, Catriona , Labotka, Richard, Kumar, Shaji K , Gupta, Neeraj , Dimopoulos, Meletios A , Delimpasi, Sosana , Dimopoulos, Meletios Α.

Mayo Clinic

British Journal of Haematology | November 21, 2018 | Volume: 184 | Issue: 4 | Pages: 536-546

10.1111/bjh.15679 | PMID 30460684 Get It

SummaryThere is a need for efficacious, convenient treatments with long‐term tolerability for patients with relapsed/refractory multiple myeloma (RRMM). This phase 2 study evaluated the all‐oral combination of ixazomib, cyclophosphamide and dexamethasone (ICd). Patients with RRMM received ixazomib 4 mg and cyclophosphamide 300 mg/m2 on days 1, 8 and 15, and dexamethasone 40 mg on days 1, 8, 15 and 22 in 28‐day cycles. The primary endpoint was overall response rate (ORR). Seventy‐eight patients were enrolled (median age 63·5 years). At data cut‐off, patients had received a median of 12 treatment cycles; 31% remained on treatment. ORR was 48% [16% very good partial response or better (≥VGPR)]. ORR was 64% and 32% in patients aged ≥65 and <65 years (25% and 16% ≥VGPR), respectively. At a median follow‐up of 15·2 months, median progression‐free survival (PFS) was 14·2 months, with a trend towards better PFS in patients aged ≥65 years vs. <65 years (median 18·7 months vs. 12·0 months; hazard ratio 0·62, P = 0·14). ICd was well tolerated. The most common treatment‐emergent adverse events were diarrhoea (33%), nausea (24%), upper respiratory tract infection (24%), and thrombocytopenia (22%); 10 patients (13%) had peripheral neuropathy (one grade 3). This study is registered at ClinicalTrials.gov (NCT02046070).
Turning Away From Industrial Health Care Toward Careful and Kind Care
Montori, Víctor M.

Mayo Clinic

Academic Medicine | November 21, 2018 | Volume: 94 | Issue: 6 | Pages: 768-770

10.1097/acm.0000000000002534 | PMID 30475268 Get It

The health care industry is increasingly driven by the pursuit of value. The author of this Invited Commentary believes this value is nothing more than a business rebranding of efficiency with little connection to care. Overclocked clinicians, increasingly impaired by symptoms of burnout and too focused on documenting, cannot see patients in high definition. The author shows that treatment which is blind to patients’ contexts often overwhelms patients with medical errands, a topic absent from medical curricula. Care must not be the means by which health care satisfies its industrial mission but, rather, the end for which it mobilizes its means. In unhurried consultations, clinicians must appreciate and respond sensibly to patients’ problematic situation, and care for and about them. Medical training must cultivate future clinicians who value caring over caring for value. Medical educators and trainees at all levels must turn away from industrial health care, toward careful and kind care for all.
An Individual Housing-Based Socioeconomic Status Measure Predicts Advance Care Planning and Nursing Home Utilization
Barwise, Amelia , Juhn, Young J. , Novotny, Paul J. , Jaramillo, Carolina, Wilson, Michael E. , Novotny, Paul, Barwise, Amelia K , Wi, Chung‐Il , Gajic, Ognjen

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | November 20, 2018 | Volume: 36 | Issue: 5 | Pages: 362-369

10.1177/1049909118812431 | PMID 30458635 Get It

Background: Socioeconomic status (SES) is an important determinant of disparities in health care and may play a role in end-of-life care and decision-making. The SES is difficult to retrospectively abstract from current electronic medical records and data sets. Objective: Using a validated SES measuring tool derived from home address, the HOUsing-based SocioEconomic Status index, termed HOUSES we wanted to determine whether SES is associated with differences in end-of-life care and decision-making. Design/Setting/Participants: This cross-sectional study utilized a cohort of Olmsted County adult residents admitted to 7 intensive care units (ICUs) at Mayo Rochester between June 1, 2011, and May 31, 2014. Measurements: Multiple variables that reflect decision-making and care at end of life and during critical illness were evaluated, including presence of advance directives and discharge disposition. The SES was measured by individual housing-based SES index (HOUSES index; a composite index derived from real property as a standardized z-score) at the date of admission to the ICU which was then divided into 4 quartiles. The greater HOUSES, the higher SES, outcomes were adjusted for age, 24-hour Acute Physiology and Chronic Health Evaluation III score, sex, race/ethnicity, and insurance. Results: Among the eligible 4134 participants, the addresses of 3393 (82%) were successfully geocoded and formulated into HOUSES. The adjusted odds ratios comparing HOUSES 1 versus 2, 3, and 4 demonstrated lower likelihood of advance directives −0.77(95% CI: 0.63-0.93) and lower likelihood of discharge to home −0.60(95% CI: 1.0.5-0.72). Conclusion: Lower SES, derived from a composite index of housing attributes, was associated with lower rates of advance directives and lower likelihood of discharge to home.